as of 02-18-2026 12:55pm EST
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.
| Founded: | 1990 | Country: | N/A |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 1.4B | IPO Year: | N/A |
| Target Price: | $24.33 | AVG Volume (30 days): | 1.8M |
| Analyst Decision: | Buy | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $11.15 - $28.47 | Next Earning Date: | 01-01-0001 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | 23.91% | Revenue Growth (next year): | 19.40% |
| P/E Ratio: | N/A | Index: | N/A |
| Free Cash Flow: | N/A | FCF Growth: | N/A |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
EVP, CTO & COO, Software
Avg Cost/Share
$13.73
Shares
925
Total Value
$12,703.77
Owned After
52,651
SEC Form 4
EVP, CLO & CPO
Avg Cost/Share
$13.80
Shares
776
Total Value
$10,705.39
Owned After
22,859
SEC Form 4
CAO
Avg Cost/Share
$13.79
Shares
752
Total Value
$10,370.38
Owned After
26,597
SEC Form 4
See Remarks
Avg Cost/Share
$13.51
Shares
1,230
Total Value
$16,617.30
Owned After
19,385
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Lorton Kenneth Patrick | SDGR | EVP, CTO & COO, Software | Feb 10, 2026 | Sell | $13.73 | 925 | $12,703.77 | 52,651 | |
| Tran Yvonne | SDGR | EVP, CLO & CPO | Feb 10, 2026 | Sell | $13.80 | 776 | $10,705.39 | 22,859 | |
| Herman Jenny | SDGR | CAO | Feb 10, 2026 | Sell | $13.79 | 752 | $10,370.38 | 26,597 | |
| Abel Robert Lorne | SDGR | See Remarks | Feb 9, 2026 | Sell | $13.51 | 1,230 | $16,617.30 | 19,385 |
See how SDGR stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "SDGR Schrodinger Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.